Hercules Technology Growth Capital Inc  

(Public, NYSE:HTGC)   Watch this stock  
Find more results for NASDAQ:HTGC
13.20
-0.10 (-0.75%)
Real-time:   9:51AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 13.16 - 13.25
52 week 9.30 - 13.71
Open 13.25
Vol / Avg. 12,014.00/632,724.00
Mkt cap 812.51M
P/E 15.13
Div/yield 0.27/8.18
EPS 0.87
Shares 61.55M
Beta 1.43
Inst. own 54%
Jul 29, 2013
Q2 2013 Hercules Technology Growth Capital Earnings Release Add to calendar
May 29, 2013
Hercules Technology Growth Capital Annual Shareholder Meeting - 10:00AM EDT - Add to calendar
May 16, 2013
Hercules Technology Growth Capital at Wells Fargo Specialty Finance Conference
May 13, 2013
Hercules Technology Growth Capital at JMP Securities' Research Conference
May 6, 2013
Q1 2013 Hercules Technology Growth Capital Earnings Release
May 2, 2013
Q1 2013 Hercules Technology Growth Capital Earnings Conference Call
Mar 5, 2013
Hercules Technology Growth Capital at Sandler O'Neill West Coast Financial Services Conference
Feb 28, 2013
Q4 2012 Hercules Technology Growth Capital Earnings Conference Call
Feb 25, 2013
Q4 2012 Hercules Technology Growth Capital Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 53.91% 47.95%
Operating margin 48.56% 49.33%
EBITD margin - 49.63%
Return on average assets 5.73% 5.00%
Return on average equity 11.83% 9.66%
Employees 56 -
Carbon Disclosure Rating - -

Address

Suite 310 400 Hamilton Avenue
PALO ALTO, CA 94301
United States - Map
+1-650-2893060 (Phone)
+1-650-4739194 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Hercules Technology Growth Capital, Inc. (HTGC) is an internally managed, non-diversified closed-end investment company. The Company is a specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and clean-technology industries at all stages of development. The Company's investment objective is to maximize the Company's portfolio total return by generating current income from its debt investments and capital appreciation from its equity-related investments. The Company invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The Company also makes investments in qualifying small businesses through two wholly-owned, small business investment company (SBIC) subsidiaries, Hercules Technology II, L.P. (HT II) and Hercules Technology III, L.P. (HT III).

Officers and directors

Manuel A. Henriquez Chairman of the Board, President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Jessica T. Baron Chief Financial Officer, Vice President - Finance, Corporate Controller
Age: 37
Bio & Compensation  - Reuters
Parag I. Shah Senior Managing Director and Life Sciences Group Head
Age: 40
Bio & Compensation  - Reuters
Scott Bluestein Chief Credit Officer
Age: 33
Bio & Compensation  - Reuters
Todd Jaquez-Fissori Clean Technology Group Head, Technology Group Head
Age: 41
Bio & Compensation  - Reuters
Allyn C. Woodward Jr. Lead Independent Director
Age: 71
Bio & Compensation  - Reuters
Robert P. Badavas Independent Director
Age: 59
Bio & Compensation  - Reuters
Joseph W. Chow Independent Director
Age: 59
Bio & Compensation  - Reuters